- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Spruce Biosciences Inc (SPRB)
Spruce Biosciences Inc stock price live, this page displays OTC SPRB stock exchange data. View the SPRB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Spruce Biosciences Inc real time stock price chart below.
What Is the Spruce Biosciences Inc Stock Price Today?
The Spruce Biosciences Inc stock price today is 0.1080.
What Is the Stock Symbol for Spruce Biosciences Inc?
The stock symbol for Spruce Biosciences Inc is ""SPRB.""
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRB quote. (ISIN: US85209E1091)
What Is the Spruce Biosciences Inc Stock Price Today?
The Spruce Biosciences Inc stock price today is 0.1080.
What Is the Stock Symbol for Spruce Biosciences Inc?
The stock symbol for Spruce Biosciences Inc is ""SPRB.""
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRB quote. (ISIN: US85209E1091)
OTC Markets
Currency in USD
0.1080
0.0000(0.00%)
Delayed Data·
Fair Value
An estimate of a Spruce's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1056
0.1175
52 wk Range
0.0570
0.6080
SPRB Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Spruce's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.10560.1175
52 wk Range
0.05700.6080
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SPRB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Spruce's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
1.0000
Upside
+825.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Spruce Biosciences regains Nasdaq compliance path
- Investing.com
- Form 8K Spruce Biosciences Inc For: 12 June
- Investing.com
- Spruce Biosciences regains Nasdaq compliance path
- Investing.com
- Form 8K Spruce Biosciences Inc For: 12 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Spruce Biosciences Inc Company Profile
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sleeping patterns. In addition, the company develops SPR202 for the treatment of Congenital Adrenal Hyperplasia (CAH), a chronic and potentially life-threatening rare disease with no cure, and SPR204, a monoclonal antibody antagonist for Post-Bariatric Hypoglycemia. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize various pharmaceutical compounds. It also has a collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize Tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.
Spruce Biosciences Inc SWOT Analysis
Tildacerfont Trials | Spruce Biosciences' future hinges on pivotal CAHmelia-204 and CAHptain-205 trials for tildacerfont, with results expected in Q4 2024 |
Market Dynamics | Explore the competitive landscape of CAH treatment, with Spruce facing challenges from Neurocrine Biosciences' crinecerfont in a market of 20,000-30,000 US patients |
Financial Health | With $70M cash runway through 2025, Spruce Biosciences navigates critical development phases while exploring strategic alternatives to maximize shareholder value |
Analyst Outlook | Price targets range from $1.50 to $3.00, reflecting varied perspectives on Spruce's potential in CAH treatment and expansion into Major Depressive Disorde |
Compare SPRB to Peers and Sector
Metrics to compare | SPRB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −4.1x | −0.5x | |
PEG Ratio | 0.01 | −0.20 | 0.00 | |
Price/Book | 0.3x | 1.9x | 2.6x | |
Price / LTM Sales | 1.7x | 9.4x | 3.2x | |
Upside (Analyst Target) | - | 70.9% | 41.2% | |
Fair Value Upside | Unlock | 25.1% | 6.2% | Unlock |
Analyst Ratings
0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1.0000
(+825.93% Upside)
Earnings
Latest Release
May 06, 2025
EPS / Forecast
-0.32 / -0.17
Revenue / Forecast
-- / 500.00K
People Also Watch
FAQ
What Stock Exchange Does Spruce Trade On?
Spruce is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Spruce?
The stock symbol for Spruce is "SPRB."
What Is the Spruce Market Cap?
As of today, Spruce market cap is 4.77M.
What Is Spruce's Earnings Per Share (TTM)?
The Spruce EPS (TTM) is -1.32.
When Is the Next Spruce Earnings Date?
Spruce will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is SPRB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Spruce Stock Split?
Spruce has split 0 times.
How Many Employees Does Spruce Have?
Spruce has 20 employees.
What is the current trading status of Spruce (SPRB)?
As of 29 Jul 2025, Spruce (SPRB) is trading at a price of 0.11, with a previous close of 0.11. The stock has fluctuated within a day range of 0.11 to 0.12, while its 52-week range spans from 0.06 to 0.61.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.